The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors

The biology , function , and biomedical applications of exosomes

Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770

Nanocarriers as an emerging platform for cancer therapy

Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710

Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin

Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323

Stimuli-responsive nanocarriers for drug delivery

Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289

Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy

Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527

Neutrophil recruitment and function in health and inflammation

Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472

Analysis of nanoparticle delivery to tumours

Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218

Tumour exosome integrins determine organotropic metastasis

Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery

Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523

The biology and function of fibroblasts in cancer

Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366

The extracellular matrix at a glance

Frantz, C., Stewart, K. M., & Weaver, V. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.023820 · Cited by 4,334

Tumour-associated macrophages as treatment targets in oncology

Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,182

Innate and adaptive immune cells in the tumor microenvironment

Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148

Mesenchymal stem cells in health and disease

Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature reviews. Immunology · doi:10.1038/nri2395 · Cited by 3,838

Strategies in the design of nanoparticles for therapeutic applications

Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651

Coordinated regulation of myeloid cells by tumours

Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206

Knocking down barriers: advances in siRNA delivery

Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115

Monocyte recruitment during infection and inflammation

Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015

Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size

Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429

Applications of nanoparticles in biology and medicine

Salata, O. (2004) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-2-3 · Cited by 2,334

Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology

Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283

Hypoxia in cancer: significance and impact on clinical outcome

Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240

In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags

Qian, X., Peng, X.-H., Ansari, D. O., Yin-Goen, Q., Chen, G. Z., Shin, D. M., Yang, L., Young, A. N., Wang, M. D., & Nie, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1377 · Cited by 2,201

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195

Engineered Nanoparticles for Drug Delivery in Cancer Therapy

Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164

Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats

Longmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149

Revisiting STAT3 signalling in cancer: new and unexpected biological functions

Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137

The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy

Muz, B., de la Puente, P., Azab, F., & Azab, A. K. (2015) · Hypoxia · doi:10.2147/hp.s93413 · Cited by 2,066

Immunosuppressive networks in the tumour environment and their therapeutic relevance

Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057

Matrix metalloproteinases and tumor metastasis

Deryugina, E. I., & Quigley, J. P. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7886-9 · Cited by 1,974

Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging

Lee, J.-H., Huh, Y.-M., Jun, Y.-W., Seo, J.-W., Jang, J.-T., Song, H.-T., Kim, S., Cho, E.-J., Yoon, H.-G., Suh, J.-S., et al. (2007) · Nature Medicine · doi:10.1038/nm1467 · Cited by 1,897

Delivery materials for siRNA therapeutics

Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800

Nanoparticles in the clinic: an update

Anselmo, A. C., & Mitragotri, S. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10143 · Cited by 1,766

Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer

O’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,739

The entry of nanoparticles into solid tumours

Sindhwani, S., Syed, A. M., Ngai, J., Kingston, B. R., Maiorino, L., Rothschild, J., MacMillan, P., Zhang, Y., Rajesh, N. U., Hoang, T., et al. (2020) · Nature Materials · doi:10.1038/s41563-019-0566-2 · Cited by 1,732

Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery

Torchilin, V. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4333 · Cited by 1,674

The emerging nanomedicine landscape

Wagner, V., Dullaart, A., Bock, A., & Zweck, A. (2006) · Nature Biotechnology · doi:10.1038/nbt1006-1211 · Cited by 1,657

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

Rosenberg, S. A., Restifo, N. P., Yang, J. C.-H., Morgan, R. A., & Dudley, M. E. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2355 · Cited by 1,654

Particle size-dependent organ distribution of gold nanoparticles after intravenous administration

de Jong, W. H., Hagens, W. I., Krystek, P., Burger, M. C., Sips, A. J. A. M., & Geertsma, R. E. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.037 · Cited by 1,620

Pharmacokinetics and Biodistribution of Nanoparticles

Li, S., & Huang, L. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800049w · Cited by 1,603

Nanoparticle Delivery of Cancer Drugs

Wang, A. Z., Langer, R., & Farokhzad, O. C. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-040210-162544 · Cited by 1,575

Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery

Fang, R. H., Hu, C. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,521

Chemistry in living systems

Prescher, J. A., & Bertozzi, C. R. (2005) · Nature Chemical Biology · doi:10.1038/nchembio0605-13 · Cited by 1,473

Nanoparticle uptake: The phagocyte problem

Gustafson, H. H., Holt‐Casper, D., Grainger, D. W., & Ghandehari, H. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.006 · Cited by 1,458

In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice

Liu, Z., Cai, W., He, L., Nakayama-Ratchford, N., Chen, K., Sun, X., Chen, X. S., & Dai, H. (2006) · Nature Nanotechnology · doi:10.1038/nnano.2006.170 · Cited by 1,448

Extracellular vesicles for drug delivery.

Vader, P., Mol, E. A., Pasterkamp, G., & Schiffelers, R. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.006 · Cited by 1,319

Immune cell migration in inflammation: present and future therapeutic targets

Luster, A. D., Alon, R., & von Andrian, U. H. (2005) · Nature Immunology · doi:10.1038/ni1275 · Cited by 1,313

Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers

Schöttler, S., Becker, G., Winzen, S., Steinbach, T., Mohr, K., Landfester, K., Mailänder, V., & Wurm, F. R. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.330 · Cited by 1,272

Tumor targeting via EPR: Strategies to enhance patient responses

Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262

Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers

Jain, R. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3653 · Cited by 1,248

In vivo Biodistribution and Highly Efficient Tumour Targeting of Carbon Nanotubes in Mice

Liu, Z., Cai, W., He, L., Nakayama-Ratchford, N., Chen, K., Sun, X., Chen, X. S., & Dai, H. (2020) · doi:10.1201/9780429399039-14 · Cited by 1,213

Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas

Aboody, K. S., Brown, A. B., Rainov, N. G., Bower, K. A., Liu, S., Yang, W., Small, J. E., Herrlinger, U., Ourednik, V., Black, P. M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12846 · Cited by 1,207

Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions

Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,174

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

Maeda, H., Bharate, G. Y., & Daruwalla, J. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,171

Role of extracellular matrix assembly in interstitial transport in solid tumors.

Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165

Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers

Wahajuddin, M., & Arora, S. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30320 · Cited by 1,148

History of myeloid-derived suppressor cells

Talmadge, J. E., & Gabrilovich, D. I. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3581 · Cited by 1,148

Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,129

Rethinking cancer nanotheranostics

Chen, H., Zhang, W., Zhu, G., Xie, J., & Chen, X. S. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.24 · Cited by 1,113

Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions

Felfoul, O., Mohammadi, M., Taherkhani, S., de Lanauze, D., Xu, Y. Z., Loghin, D., Essa, S., Jančík, S., Houle, D., Lafleur, M., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.137 · Cited by 1,111

Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner

Chauhan, V. P., Stylianopoulos, T., Martin, J. D., Popović, Z., Chen, O., Kamoun, W. S., Bawendi, M. G., Fukumura, D., & Jain, R. K. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.45 · Cited by 1,101

Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs

Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R., & Ruoslahti, E. I. (2010) · Science · doi:10.1126/science.1183057 · Cited by 1,095

Lessons from phase III clinical trials on anti-VEGF therapy for cancer

Jain, R. K., Duda, D. G., Clark, J. W., & Loeffler, J. S. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0403 · Cited by 1,047

Intelligent Albumin–MnO 2 Nanoparticles as pH‐/H 2 O 2 ‐Responsive Dissociable Nanocarriers to Modulate Tumor Hypoxia for Effective Combination Therapy

Chen, Q., Feng, L., Liu, J., Zhu, W., Dong, Z., Wu, Y., & Liu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201601902 · Cited by 1,042

Mechanism of hard-nanomaterial clearance by the liver

Tsoi, K. M., MacParland, S. A., Ma, X., Spetzler, V. N., Echeverri, J. A., Ouyang, B., Fadel, S. M., Sykes, E. A., Goldaracena, N., Kaths, J. M., et al. (2016) · Nature Materials · doi:10.1038/nmat4718 · Cited by 1,035

The seed and soil hypothesis revisited—The role of tumor‐stroma interactions in metastasis to different organs

Langley, R. R., & Fidler, I. J. (2011) · International Journal of Cancer · doi:10.1002/ijc.26031 · Cited by 1,002

Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles

Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 1,001

Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence

Xue, J., Zhao, Z., Zhang, L., Xue, L., Shen, S., Wen, Y., Wei, Z., Wang, L., Kong, L., Sun, H., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.54 · Cited by 961

Cancer nanomedicine for combination cancer immunotherapy

Nam, J., Son, S., Park, K. S., Zou, W., Shea, L. D., & Moon, J. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0108-1 · Cited by 955

Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues

Murdoch, C., Giannoudis, A., & Lewis, C. E. (2004) · Blood · doi:10.1182/blood-2004-03-1109 · Cited by 943

Nanoparticle Targeting of Anticancer Drug Improves Therapeutic Response in Animal Model of Human Epithelial Cancer

Kukowska‐Latallo, J. F., Candido, K. A., Cao, Z., Nigavekar, S. S., Majoros, I., Thomas, T. P., Balogh, L. P., Khan, M. K., & Baker, J. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3921 · Cited by 912

Theranostic Nanomedicine

Lammers, T., Aime, S., Hennink, W. E., Storm, G., & Kiessling, F. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar200019c · Cited by 906

Cancer Cell Membrane–Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal Therapy

Chen, Z., Zhao, P., Luo, Z., Zheng, M., Tian, H., Gong, P., Gao, G., Pan, H., Liu, L., Ma, A.-Q., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b04695 · Cited by 899

Multifunctional magnetic nanoparticles for targeted imaging and therapy

MCCARTHY, J., & WEISSLEDER, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.014 · Cited by 892

Advances in Biomaterials for Drug Delivery

Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018) · Advanced Materials · doi:10.1002/adma.201705328 · Cited by 890

Use of Metal Oxide Nanoparticle Band Gap To Develop a Predictive Paradigm for Oxidative Stress and Acute Pulmonary Inflammation

Zhang, H., Ji, Z., Xia, T., Meng, H., Low‐Kam, C., Liu, R., Pokhrel, S., Lin, S., Wang, X., Liao, Y., et al. (2012) · ACS Nano · doi:10.1021/nn3010087 · Cited by 829

Understanding ultrasound induced sonoporation: Definitions and underlying mechanisms

Lentacker, I., Cock, I. D., Deckers, R., Smedt, S. C. D., & MOONEN, C. T. W. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.008 · Cited by 824

Clinical Translation of Nanomedicine

Min, Y., Caster, J. M., Eblan, M. J., & Wang, A. Z. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00116 · Cited by 803

Tumor Necrosis Factor, Other Cytokines and Disease

Tracey, K. J., & Cerami, A. (1993) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.09.110193.001533 · Cited by 794

Cancer Cell Membrane Camouflaged Cascade Bioreactor for Cancer Targeted Starvation and Photodynamic Therapy

Li, S., Cheng, H. B., Xie, B., Qiu, W., Zeng, J.-Y., Li, C., Wan, S., Zhang, L., Liu, W., & Zhang, X. (2017) · ACS Nano · doi:10.1021/acsnano.7b02533 · Cited by 783

Causes and consequences of tumour acidity and implications for treatment

Stubbs, M., McSheehy, P. M. J., Griffiths, J. R., & Bashford, C. L. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01615-9 · Cited by 781

Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth

Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., & Takeyama, H. (2015) · Cancers · doi:10.3390/cancers7040902 · Cited by 774

Microwave Tumor Ablation: Mechanism of Action, Clinical Results, and Devices

Lubner, M. G., Brace, C. L., Hinshaw, J. L., & Lee, F. T. (2010) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2010.04.007 · Cited by 764

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles

Stephan, M. T., Moon, J. J., Um, S. H., Bershteyn, A., & Irvine, D. J. (2010) · Nature Medicine · doi:10.1038/nm.2198 · Cited by 752

Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors

Diop-Frimpong, B., Chauhan, V. P., Krane, S., Boucher, Y., & Jain, R. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018892108 · Cited by 733

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers

Gu, F., Zhang, L., Teply, B. A., Mann, N., Wang, A. Z., Radovic‐Moreno, A. F., Langer, R., & Farokhzad, O. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711714105 · Cited by 714

Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells

Viguier, M. A., Lemaı̂tre, F., VEROLA, O., Cho, M.-S., Gorochov, G., Dubertret, L., Bachelez, H., Kourilsky, P., & Ferradini, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1444 · Cited by 707

Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination

Yang, R., Xu, J., Xu, L., Sun, X., Chen, Q., Zhao, Y., Peng, R., & Liu, Z. (2018) · ACS Nano · doi:10.1021/acsnano.7b09041 · Cited by 704

Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles

Choi, C. H. J., Alabi, C. A., Webster, P. C., & Davis, M. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914140107 · Cited by 699

Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer

Cao, H., Dan, Z., He, X., Zhang, Z., Yu, H., Yin, Q., & Li, Y. (2016) · ACS Nano · doi:10.1021/acsnano.6b03148 · Cited by 697

NK cells and cancer immunosurveillance

Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682

A Decade of the Protein Corona

Ke, P. C., Lin, S., Parak, W. J., Davis, T. P., & Caruso, F. (2017) · ACS Nano · doi:10.1021/acsnano.7b08008 · Cited by 672

Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors

Dai, Q., Wilhelm, S., Ding, D., Syed, A. M., Sindhwani, S., Zhang, Y., Chen, Y. Y., MacMillan, P., & Chan, W. C. W. (2018) · ACS Nano · doi:10.1021/acsnano.8b03900 · Cited by 672

Protein corona: a new approach for nanomedicine design

Nguyen, V. H., & Lee, B. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s129300 · Cited by 669

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

Tang, L., Zheng, Y., Melo, M. B., Mabardi, L., Castaño, A. P., Xie, Y., Li, N., Kudchodkar, S. B., Wong, H. C., Jeng, E. K., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4181 · Cited by 663

Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy

Cantelmo, A. R., Conradi, L.-C., Brajic, A., Goveia, J., Kalucka, J., Pircher, A., Chaturvedi, P., Hol, J., Thienpont, B., Teuwen, L.-A., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.006 · Cited by 659

Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma

Benezra, M., Medina, O. P., ZANZONICO, P. B., Schaer, D., Ow, H., Burns, A., DeStanchina, E., Longo, V. A., Herz, E., Iyer, S. K., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45600 · Cited by 658

Investigating the Impact of Nanoparticle Size on Active and Passive Tumor Targeting Efficiency

Sykes, E. A., Chen, J., Zheng, G., & Chan, W. C. W. (2014) · ACS Nano · doi:10.1021/nn500299p · Cited by 647

Anticancer Platelet‐Mimicking Nanovehicles

Hu, Q., Sun, W., Qian, C., Wang, C., Bomba, H. N., & Gu, Z. (2015) · Advanced Materials · doi:10.1002/adma.201503323 · Cited by 638

Multifunctional Albumin–MnO2 Nanoparticles Modulate Solid Tumor Microenvironment by Attenuating Hypoxia, Acidosis, Vascular Endothelial Growth Factor and Enhance Radiation Response

Prasad, P., Gordijo, C. R., Abbasi, A. Z., Maeda, A., Ip, A., Rauth, A. M., DaCosta, R. S., & Wu, X. Y. (2014) · ACS Nano · doi:10.1021/nn405773r · Cited by 633

Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy

Järveläinen, H., Sainio, A., Koulu, M., Wight, T. N., & Penttinen, R. P. K. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001289 · Cited by 602

Erythrocyte‐Membrane‐Enveloped Perfluorocarbon as Nanoscale Artificial Red Blood Cells to Relieve Tumor Hypoxia and Enhance Cancer Radiotherapy

Gao, M., Liang, C., Song, X., Chen, Q., Jin, Q., Wang, C., & Liu, Z. (2017) · Advanced Materials · doi:10.1002/adma.201701429 · Cited by 593

Modulation of Hypoxia in Solid Tumor Microenvironment with MnO 2 Nanoparticles to Enhance Photodynamic Therapy

Zhu, W., Dong, Z., Fu, T., Liu, J., Chen, Q., Li, Y., Zhu, R., Xu, L., & Liu, Z. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201600676 · Cited by 592

A Cellular Trojan Horse for Delivery of Therapeutic Nanoparticles into Tumors

Choi, M.-R., Stanton-Maxey, K. J., Stanley, J. K., Levin, C. S., Bardhan, R., Akin, D., Badve, S., Sturgis, J. E., Robinson, J. P., Bashir, R., et al. (2007) · Nano Letters · doi:10.1021/nl072209h · Cited by 584

Ultrasound Triggered Tumor Oxygenation with Oxygen-Shuttle Nanoperfluorocarbon to Overcome Hypoxia-Associated Resistance in Cancer Therapies

Song, X., Feng, L., Liang, C., Yang, K., & Liu, Z. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b02365 · Cited by 580

Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis

Kang, T., Zhu, Q., Wei, D., Feng, J., Yao, J., Jiang, T., Song, Q., Wei, X., Chen, H., Gao, X., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06477 · Cited by 558

Adoptive T cell therapy for cancer in the clinic

June, C. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32446 · Cited by 547

Tangential Flow Filtration for Highly Efficient Concentration of Extracellular Vesicles from Large Volumes of Fluid

Busatto, S., Vilanilam, G. K., Ticer, T. D., Lin, W., Dickson, D. W., Shapiro, S. A., Bergese, P., & Wolfram, J. (2018) · Cells · doi:10.3390/cells7120273 · Cited by 538

(Intra)Cellular Stability of Inorganic Nanoparticles: Effects on Cytotoxicity, Particle Functionality, and Biomedical Applications

Soenen, S. J., Parak, W. J., Rejman, J., & Manshian, B. B. (2015) · Chemical Reviews · doi:10.1021/cr400714j · Cited by 526

An overview of clinical and commercial impact of drug delivery systems

Anselmo, A. C., & Mitragotri, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.053 · Cited by 525

The dose threshold for nanoparticle tumour delivery

Ouyang, B., Poon, W., Zhang, Y.-N., Lin, Z. P., Kingston, B. R., Tavares, A. J., Zhang, Y., Chen, J., Valic, M. S., Syed, A. M., et al. (2020) · Nature Materials · doi:10.1038/s41563-020-0755-z · Cited by 524

Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia

Scharping, N. E., Menk, A. V., Whetstone, R. D., Zeng, X., & Delgoffe, G. M. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0103 · Cited by 520

A Review of Clinical Translation of Inorganic Nanoparticles

Anselmo, A. C., & Mitragotri, S. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9780-2 · Cited by 509

Combining two strategies to improve perfusion and drug delivery in solid tumors

Stylianopoulos, T., & Jain, R. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318415110 · Cited by 508

Preferential Cancer Cell Self-Recognition and Tumor Self-Targeting by Coating Nanoparticles with Homotypic Cancer Cell Membranes

Zhu, J.-Y., Zheng, D.-W., Zhang, M.-K., Yu, W.-Y., Qiu, W.-X., Hu, J.-J., Feng, J., & Zhang, X.-Z. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b02786 · Cited by 498

Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype

Chen, D., Xie, J., Fiskesund, R., Dong, W., Liang, X., Lv, J., Jin, X., Liu, J., Mo, S., Zhang, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03225-9 · Cited by 489

Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness

Peng, F., Setyawati, M. I., Tee, J. K., Ding, X., Wang, J., Nga, M. E., Ho, H. K., & Leong, D. T. (2019) · Nature Nanotechnology · doi:10.1038/s41565-018-0356-z · Cited by 483

Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells

Jinushi, M., Chiba, S., Yoshiyama, H., Masutomi, K., Kinoshita, I., Dosaka-Akita, H., Yagita, H., Takaoka, A., & Tahara, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106645108 · Cited by 479

Life at the oxic–anoxic interface: microbial activities and adaptations

Brune, A., Frenzel, P. F., & Cypionka, H. (2000) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2000.tb00567.x · Cited by 478

Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems

Piffoux, M., Silva, A., Wilhelm, C., Gazeau, F., & Tareste, D. C. (2018) · ACS Nano · doi:10.1021/acsnano.8b02053 · Cited by 474

Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes

Gao, W., Hu, C. J., Fang, R. H., Luk, B. T., Su, J., & Zhang, L. (2013) · Advanced Materials · doi:10.1002/adma.201300638 · Cited by 467

Streptavidin–biotin technology: improvements and innovations in chemical and biological applications

Dundas, C. M., Demonte, D., & Park, S. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5232-z · Cited by 467

Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE–cadherin

Setyawati, M. I., Tay, C. Y., Chia, S. L., Goh, S. L. G., Fang, W., Neo, M. J., Chong, H. C., Tan, S., Loo, S. C. J., Ng, K. W., et al. (2013) · Nature Communications · doi:10.1038/ncomms2655 · Cited by 465

Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes

Liu, D., Mori, A., & Huang, L. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90136-a · Cited by 464

Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy

Wang, Y., Xie, Y., Li, J., Peng, Z., Sheinin, Y. M., Zhou, J., & Oupický, D. (2017) · ACS Nano · doi:10.1021/acsnano.6b08731 · Cited by 463

cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

Yang, X., Hong, H., Grailer, J. J., Rowland, I. J., Javadi, A., Hurley, S. A., Xiao, Y., Yang, Y., Zhang, Y., Nickles, R. J., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.006 · Cited by 442

A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dots

Ye, L., Yong, K., Liu, L., Roy, I., Hu, R., Zhu, J., Cai, H., Law, W., Liu, J., Wang, K., et al. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.74 · Cited by 432

Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature

Cai, W., Chen, K., Li, Z., Gambhir, S. S., & Chen, X. S. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.043216 · Cited by 431

Erythrocyte Membrane Is an Alternative Coating to Polyethylene Glycol for Prolonging the Circulation Lifetime of Gold Nanocages for Photothermal Therapy

Piao, J., Wang, L., Gao, F., You, Y., Xiong, Y., & Yang, L. (2014) · ACS Nano · doi:10.1021/nn503779d · Cited by 428

A Reexamination of Active and Passive Tumor Targeting by Using Rod-Shaped Gold Nanocrystals and Covalently Conjugated Peptide Ligands

Huang, X., Peng, X., Wang, Y., Wang, Y., Shin, D. M., El‐Sayed, M. A., & Nie, S. (2010) · ACS Nano · doi:10.1021/nn102055s · Cited by 427

In-depth analysis of the membrane and cytosolic proteome of red blood cells

Pasini, E. M., Kirkegaard, M., Mortensen, P., Lutz, H. U., Thomas, A. W., & Mann, M. (2006) · Blood · doi:10.1182/blood-2005-11-007799 · Cited by 426

Biological Identity of Nanoparticles In Vivo : Clinical Implications of the Protein Corona

Caracciolo, G., Farokhzad, O. C., & Mahmoudi, M. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.08.011 · Cited by 426

Hypoxia Induced by Upconversion‐Based Photodynamic Therapy: Towards Highly Effective Synergistic Bioreductive Therapy in Tumors

Liu, Y., Liu, Y., Bu, W., Cheng, C., Zuo, C., Xiao, Q., Sun, Y., Ni, D., Zhang, C., Liu, J., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500478 · Cited by 425

Arginine and Immunity

Popovič, P., Zeh, H. J., & Ochoa, J. B. (2007) · Journal of Nutrition · doi:10.1093/jn/137.6.1681s · Cited by 406

Pericytes and vessel maturation during tumor angiogenesis and metastasis

Raza, A., Franklin, M. J., & Dudek, A. Z. (2010) · American Journal of Hematology · doi:10.1002/ajh.21745 · Cited by 402

Amino acid distributions in integral membrane protein structures

Ulmschneider, M. B., & Sansom, M. S. P. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00299-1 · Cited by 401

Drug delivery by red blood cells: vascular carriers designed by mother nature

Muzykantov, V. R. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003610633 · Cited by 399

64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer

Lee, H., Shields, A. F., Siegel, B. A., Miller, K. D., Krop, I. E., Ma, C. X., LoRusso, P. M., Münster, P. N., Campbell, K., Gaddy, D. F., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3193 · Cited by 397

In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy

Melancon, M. P., Lü, W., Yang, Z., Zhang, R., Cheng, Z., Elliot, A. M., Stafford, J., Olson, T. Y., Zhang, J. Z., & Li, C. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0016 · Cited by 396

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.

Eggermont, A. M. M., Koops, H. S., Liénard, D., Kroon, B. B. R., van Geel, A. N., Hoekstra, H. J., & Lejeune, F. J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2653 · Cited by 395

Ecology, Diversity, and Evolution of Magnetotactic Bacteria

Lefèvre, C., & Bazylinski, D. (2013) · Microbiology and Molecular Reviews · doi:10.1128/mmbr.00021-13 · Cited by 391

Epidermal Growth Factor Receptor–Targeted Immunoliposomes Significantly Enhance the Efficacy of Multiple Anticancer DrugsIn vivo

Mamot, C., Drummond, D. C., Noble, C. O., Kallab, V., Guo, Z., Hong, K., Kirpotin, D. B., & Park, J. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1093 · Cited by 383

Platelets and cancer

Nash, G., Turner, L., Scully, M. F., & Kakkar, A. K. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00789-1 · Cited by 378

Macrophage Cell Membrane Camouflaged Au Nanoshells for in Vivo Prolonged Circulation Life and Enhanced Cancer Photothermal Therapy

Xuan, M., Shao, J., Dai, L., Li, J., & He, Q. Z. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b00853 · Cited by 377

Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors.

Campbell, R. B., Fukumura, D., Brown, E. B., Mazzola, L. M., Izumi, Y., Jain, R. K., Torchilin, V. P., & Munn, L. L. (2002) · PubMed · Cited by 372

Grapefruit-Derived Nanovectors Use an Activated Leukocyte Trafficking Pathway to Deliver Therapeutic Agents to Inflammatory Tumor Sites

Wang, Q., Ren, Y., Mu, J., Egilmez, N. K., Zhuang, X., Deng, Z., Zhang, L., Yan, J., Miller, D. M., & Zhang, H. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3095 · Cited by 371

Self-assembly of extracellular vesicle-like metal–organic framework nanoparticles for protection and intracellular delivery of biofunctional proteins

Cheng, G., Li, W., Ha, L., Han, X., Hao, S., Wan, Y., Wang, Z., Dong, F., Zou, X., Mao, Y., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b03584 · Cited by 371

Odyssey of a cancer nanoparticle: From injection site to site of action

Nichols, J. W., & Bae, Y. H. (2012) · Nano Today · doi:10.1016/j.nantod.2012.10.010 · Cited by 369

Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude

Brenner, J. S., Pan, D. C., Myerson, J. W., Marcos-Contreras, O. A., Villa, C. H., Patel, P., Hekierski, H., Chatterjee, S., Tao, J.-Q., Parhiz, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05079-7 · Cited by 363

Drug Delivery with Extracellular Vesicles: From Imagination to Innovation

de Jong, O. G., Kooijmans, S. A. A., Murphy, D. E., Jiang, L., Evers, M. J. W., Sluijter, J. P. G., Vader, P., & Schiffelers, R. M. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00109 · Cited by 362

Delivering Nanoparticles to Lungs while Avoiding Liver and Spleen through Adsorption on Red Blood Cells

Anselmo, A. C., Gupta, V., Zern, B. J., Pan, D., Zakrewsky, M., Muzykantov, V., & Mitragotri, S. (2013) · ACS Nano · doi:10.1021/nn404853z · Cited by 355

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation

Batchelor, T. T., Gerstner, E. R., Emblem, K. E., Duda, D. G., Kalpathy–Cramer, J., Snuderl, M., Ancukiewicz, M., Polaskova, P., Pinho, M. C., Jennings, D. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318022110 · Cited by 353

The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles

Lee, H., Fonge, H., Hoang, B., Reilly, R. M., & Allen, C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100038h · Cited by 349

Size-Controlled Dissolution of Silver Nanoparticles at Neutral and Acidic pH Conditions: Kinetics and Size Changes

Peretyazhko, T. S., Zhang, Q., & Colvin, V. L. (2014) · Environmental Science & Technology · doi:10.1021/es5023202 · Cited by 348

In Vivo Tumor Targeting and Image-Guided Drug Delivery with Antibody-Conjugated, Radiolabeled Mesoporous Silica Nanoparticles

Chen, F., Hong, H., Zhang, Y., Valdovinos, H. F., Shi, S., Kwon, G. S., Theuer, C. P., Barnhart, T. E., & Cai, W. (2013) · ACS Nano · doi:10.1021/nn403617j · Cited by 346

Tumor site-specific silencing of NF-κB p65 by targeted hollow gold nanospheres-mediated photothermal transfection

Lu, W., Zhang, G., Zhang, R., Flores, L., Huang, Q., Gelovani, J., & Li, C. X. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3379 · Cited by 335

Tumor-targeted Delivery of siRNA by Self-assembled Nanoparticles

Li, S., Chen, Y.-C., Hackett, M., & Huang, L. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300323 · Cited by 333

TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma

Liu, J., Liao, S., Diop-Frimpong, B., Chen, W., Goel, S., Naxerova, K., Ancukiewicz, M., Boucher, Y., Jain, R. K., & Xu, L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117610109 · Cited by 332

Silica Nanorattle–Doxorubicin-Anchored Mesenchymal Stem Cells for Tumor-Tropic Therapy

Li, L., Guan, Y., Liu, H., Hao, N., Liu, T., Meng, X., Fu, C., Li, Y., Qu, Q.-L., Zhang, Y., et al. (2011) · ACS Nano · doi:10.1021/nn202399w · Cited by 331

Tumor cell intravasation

Chiang, S., Cabrera, R. M., & Segall, J. E. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00238.2015 · Cited by 327

Use of a High-Throughput Screening Approach Coupled with In Vivo Zebrafish Embryo Screening To Develop Hazard Ranking for Engineered Nanomaterials

George, S., Xia, T., Ralló, R., Zhao, Y., Ji, Z., Lin, S., Wang, X., Zhang, H., France, B., Schoenfeld, D. A., et al. (2011) · ACS Nano · doi:10.1021/nn102734s · Cited by 326

Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines

Dobrovolskaia, M. A., & McNeil, S. E. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.025 · Cited by 324

Macrophage Uptake of Core−Shell Nanoparticles Surface Modified with Poly(ethylene glycol)

Zahr, A. S., Davis, C. A., & Pishko, M. V. (2006) · Langmuir · doi:10.1021/la060951b · Cited by 324

Targeted Photothermal Ablation of Murine Melanomas with Melanocyte-Stimulating Hormone Analog–Conjugated Hollow Gold Nanospheres

Lü, W., Xiong, C., Zhang, G., Huang, Q., Zhang, R., Zhang, J. Z., & Li, C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1480 · Cited by 324

Neuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progression

Miao, H., Lee, P. P., Lin, H., Söker, S., & Klagsbrun, M. (2000) · The FASEB Journal · doi:10.1096/fj.00-0250com · Cited by 318

In Vivo Targeting and Imaging of Tumor Vasculature with Radiolabeled, Antibody-Conjugated Nanographene

Hong, H., Yang, K., Zhang, Y., Engle, J. W., Feng, L., Yang, Y., Nayak, T. R., Goel, S., Bean, J., Theuer, C. P., et al. (2012) · ACS Nano · doi:10.1021/nn204625e · Cited by 316

Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells

Huang, B., Abraham, W. D., Zheng, Y., Bustamante-Lopez, S. C., Luo, S., & Irvine, D. J. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5447 · Cited by 316

Personalized protein coronas: a “key” factor at the nanobiointerface

Hajipour, M. J., Laurent, S., Aghaie, A., Rezaee, F., & Mahmoudi, M. (2014) · Biomaterials Science · doi:10.1039/c4bm00131a · Cited by 315

Turning Erythrocytes into Functional Micromotors

Wu, Z., Li, T., Li, J., Gao, W. F., Xu, T., Christianson, C., Gao, W., Galarnyk, M., He, Q. Z., Zhang, L., et al. (2014) · ACS Nano · doi:10.1021/nn506200x · Cited by 312

‘Marker-of-self’ functionalization of nanoscale particles through a top-down cellular membrane coating approach

Hu, C. J., Fang, R. H., Luk, B. T., Chen, K. N. H., Carpenter, C. W., Gao, W., Zhang, K., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr00015j · Cited by 310

Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy

Zhou, H., Fan, Z., Deng, J., Lemons, P. K., Arhontoulis, D. C., Bowne, W. B., & Cheng, H. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b00820 · Cited by 293

Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles

Hu, K., Miao, L., Goodwin, T. J., Li, J., Liu, Q., & Huang, L. (2017) · ACS Nano · doi:10.1021/acsnano.7b01522 · Cited by 293

Systematic Surface Engineering of Magnetic Nanoworms for In vivo Tumor Targeting

Park, J., von Maltzahn, G., Zhang, L., Derfus, A. M., Simberg, D., Harris, T. J., Ruoslahti, E. I., Bhatia, S. N., & Sailor, M. J. (2009) · Small · doi:10.1002/smll.200801789 · Cited by 290

The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion.

Fingar, V. H., Wieman, T. J., Wiehle, S., & Cerrito, P. B. (1992) · PubMed · Cited by 289

Tailoring nanoparticle designs to target cancer based on tumor pathophysiology

Sykes, E. A., Dai, Q., Sarsons, C. D., Chen, J., Rocheleau, J. V., Hwang, D. M., Zheng, G., Cramb, D. T., Rinker, K. D., & Chan, W. C. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521265113 · Cited by 287

Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts

Zhong, Y., Zhang, J., Cheng, R., Deng, C., Meng, F., Xie, F., & Zhong, Z. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.012 · Cited by 285

Neutrophil-Mediated Delivery of Therapeutic Nanoparticles across Blood Vessel Barrier for Treatment of Inflammation and Infection

Chu, D., Gao, J., & Wang, Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b05583 · Cited by 283

In Vivo Antitumor Activity of the Folate-Conjugated pH-Sensitive Polymeric Micelle Selectively Releasing Adriamycin in the Intracellular Acidic Compartments

Bae, Y., Nishiyama, N., & Kataoka, K. (2007) · Bioconjugate Chemistry · doi:10.1021/bc060401p · Cited by 281

Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles

Gao, H., Qian, J., Cao, S., Yang, Z. H., Pang, Z., Pan, S., Fan, L., Xi, Z., Jiang, X., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.058 · Cited by 280

miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity

O’Brien, K., Lowry, M. C., Corcoran, C., Martínez, V. G., Daly, M., Rani, S., Gallagher, W. M., Radomski, M. W., MacLeod, R. A. F., & O’Driscoll, L. (2015) · Oncotarget · doi:10.18632/oncotarget.5192 · Cited by 278

Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors

Miao, L., Lin, C. M., & Huang, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.017 · Cited by 270

Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium

Glinsky, V. V., Glinsky, G. V., Glinskii, O. V., Huxley, V. H., Turk, J. R., Mossine, V. V., Deutscher, S. L., Pienta, K. J., & Quinn, T. P. (2004) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2003.12.009 · Cited by 266

Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma

Zhao, Y., Cao, J., Melamed, A., Worley, M. J., Gockley, A. A., Jones, D., Nia, H. T., Zhang, Y., Stylianopoulos, T., Kumar, A. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818357116 · Cited by 265

Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors

Ojha, T., Pathak, V., Shi, Y., Hennink, W. E., Moonen, C. T. W., Storm, G., Kiessling, F., & Lammers, T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.007 · Cited by 260

Breast Cancer-Derived Lung Metastases Show Increased Pyruvate Carboxylase-Dependent Anaplerosis

Christen, S., Lorendeau, D., Schmieder, R., Broekaert, D., Metzger, K., Veys, K., Elia, I., Buescher, J. M., Orth, M. F., Davidson, S. M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.042 · Cited by 258

Bacteria-Mediated Hypoxia-Specific Delivery of Nanoparticles for Tumors Imaging and Therapy

Luo, C.-H., Huang, C.-T., Su, C., & Yeh, C. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b00262 · Cited by 256

Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy

Yang, S., & Gao, H. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.004 · Cited by 256

Multifunctional Theranostic Red Blood Cells For Magnetic‐Field‐Enhanced in vivo Combination Therapy of Cancer

Wang, C., Sun, X., Cheng, L., Yin, S., Yang, G., Li, Y., & Liu, Z. (2014) · Advanced Materials · doi:10.1002/adma.201400158 · Cited by 252

The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia

Ashton, T. M., Fokas, E., Kunz‐Schughart, L. A., Folkes, L. K., Anbalagan, S., Hüther, M., Kelly, M., Pirovano, G., Buffa, F. M., Hammond, E. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12308 · Cited by 249

Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions

Hainfeld, J. F., O’Connor, M. J., Dilmanian, F. A., Slatkin, D. N., Adams, D. J., & Smilowitz, H. M. (2011) · British Journal of Radiology · doi:10.1259/bjr/42612922 · Cited by 247

Engineering of Hollow Mesoporous Silica Nanoparticles for Remarkably Enhanced Tumor Active Targeting Efficacy

Chen, F., Hong, H., Shi, S., Goel, S., Valdovinos, H. F., Hernandez, R., Theuer, C. P., Barnhart, T. E., & Cai, W. (2014) · Scientific Reports · doi:10.1038/srep05080 · Cited by 246

Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors

Roger, M., Clavreul, A., Venier‐Julienne, M., Passirani, C., Sindji, L., Schiller, P. C., Montero‐Menei, C. N., & Meneï, P. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.048 · Cited by 246

Coating Matters: Review on Colloidal Stability of Nanoparticles with Biocompatible Coatings in Biological Media, Living Cells and Organisms

Schubert, J., & Chanana, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180601101859 · Cited by 245

On the issue of transparency and reproducibility in nanomedicine

Leong, H. S., Butler, K. S., Brinker, C. J., Azzawi, M., Conlan, R. S., Dufès, C., Owen, A., Rannard, S. P., Scott, C., Chen, C., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0496-9 · Cited by 244

Erythrocyte Membrane-Coated Upconversion Nanoparticles with Minimal Protein Adsorption for Enhanced Tumor Imaging

Rao, L., Meng, Q., Bu, L., Cai, B., Huang, Q., Sun, Z., Zhang, W., Li, A., Guo, S., Liu, W., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b14450 · Cited by 243

Dual‐Stage Light Amplified Photodynamic Therapy against Hypoxic Tumor Based on an O2 Self‐Sufficient Nanoplatform

Liu, L., Zhang, Y., Qiu, W., Zhang, L., Gao, F., Li, B., Xu, L., Fan, J., Li, Z., & Zhang, X. (2017) · Small · doi:10.1002/smll.201701621 · Cited by 241

Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB

Chen, C., Duan, Z., Yuan, Y., Li, R., Pang, L., Liang, J., Xu, X., & Wang, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b15831 · Cited by 238

Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors

Shime, H., Matsumoto, M., Oshiumi, H., Tanaka, S., Nakane, A., Iwakura, Y., Tahara, H., Inoue, N., & Seya, T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113099109 · Cited by 233

Efficient drug-delivery using magnetic nanoparticles — biodistribution and therapeutic effects in tumour bearing rabbits

Tietze, R., Lyer, S., Dürr, S., Struffert, T., Engelhorn, T., Schwarz, M., Eckert, E., Göen, T., Vasylyev, S., Peukert, W., et al. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.05.001 · Cited by 232

Current advance of nanotechnology in diagnosis and treatment for malignant tumors

Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 641

Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook

Obidiro, O. P., Battogtokh, G., & Akala, E. O. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071796 · Cited by 564

The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives

Sun, R., Xiang, J., Zhou, Q., Piao, Y., Tang, J., Shao, S., Zhou, Z., Bae, Y. H., & Shen, Y. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114614 · Cited by 474

Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics

Wei, D., Sun, Y., Zhu, H., & Fu, Q. (2023) · ACS Nano · doi:10.1021/acsnano.3c06019 · Cited by 326

Cancer nanotechnology: current status and perspectives

Kemp, J. A., & Kwon, Y. J. (2021) · Nano Convergence · doi:10.1186/s40580-021-00282-7 · Cited by 290

Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms

Zi, Y., Yang, K., He, J., Wu, Z., Liu, J., & Zhang, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114449 · Cited by 268

Enhanced permeability and retention (EPR) effect: Advances in nanomedicine for improved tumor targeting

Khan, M. S., Alqahtani, T., Shmrany, H. A., Gupta, G., Goh, K. W., Sahebkar, A., & Kesharwani, P. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214636 · Cited by 121

Regulation of oxidative stress and inflammation caused by drug accumulation in the TME based on EPR-passive strategy and active targeting

Deng, X., Zhang, Z., Ren, T., & Chen, L. (2025) · Cancer Nanotechnology · doi:10.1186/s12645-025-00342-1 · Cited by 34

The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives

Sun, R., Xiang, J., Zhou, Q., Piao, Y., Tang, J., Shao, S., Zhou, Z., Bae, Y. H., & Shen, Y. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114614 · Cited by 474

Nanomedicine: From where are we coming and where are we going?

Couvreur, P. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.020 · Cited by 22